LCI 4th Annual Symposium on Hematologic Malignancies

Share This Event

*Registration payment includes Credit Cards and Interfund Transfers ONLY.

Target Audience

Physicians, Physician Assistants, Nurse Practitioners, Pharmacists, Registered Nurses, Licensed Practical Nurses

Description

Participants will receive updates in the latest diagnostic procedures and cutting-edge treatments of malignant hematologic disorders and improve the understanding of how to incorporate newly approved drugs in current practice. The symposium will focus on hematologic malignancies that include Multiple Myeloma, Lymphoma & Leukemia. Also, information regarding the role stem cell transplantation and CAR T cell therapy in the management of these malignancies will be discussed.

Agenda
7:30 AM Registration and Breakfast
8:10 AM CAR T-cell Therapy: The New Frontier for Hematological Malignancies – Sattva Neelapu, MD
9:00 AM What’s New in Lymphoma in 2018 – Brad Kahl, MD
9:50 AM Break
10:10 AM Novel Therapeutic Strategies in Myeloma - Kenneth Anderson, MD
11:00 AM  Lunch
12:00 PM  How I Treat Polycythemia Vera in 2018 – Richard Silver, MD
12:50 PM  Closing remarks

Accreditation Statement
Carolinas HealthCare System/Charlotte AHEC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Statement
The Carolinas HealthCare System/Charlotte AHEC designates this Live Activity for a maximum of 3.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.

CEU Statement
This Live Activity fulfills the requirement of 0.35 Continuing Education Units (CEU's), representing 3.5 contact hours.*No partial credit will be awarded for CEUs and/or Contact Hours*

Location
Levine Cancer Institute - Carolinas HealthCare System
3rd Floor Conference Room 3035ABC
1021 Morehead Medical Drive
Charlotte, NC 28204


By registering for the program, you authorize Charlotte AHEC to release your name, city and state to attending commercial supporters. Please contact the program support listed below if you have any questions or concerns.

Objectives

• Define standards of care, assess and improve patient management and perform the application of recently approved therapies for patients diagnosed with hematologic malignancies such as, but not limited to, Myeloma,Lymphoma, Myeloproliferative neoplasms, Blood & Marrow Transplantation.
• Identify and perform diagnostic advances and procedures for patients diagnosed with hematologic malignancies, such as, but not limited to, Myeloma, Lymphoma, Myeloproliferative neoplasms, CAR-T cells.
• Identify and incorporate newly approved agents including CAR-T cell therapy in the treatment of Myeloma, Lymphoma, and Leukemia. They will be able to learn the new advancements in the treatments of these diseases.

Sessions